Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Abstract

Abstract Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia.

Keywords

• amiodarone
• atrial fibrillation
• QT prolongation
• torsades de Pointes